Ketamine, MDMA and Psilocybin have not yet received approval from Health Canada or the Food and Drug Administration for treating any mental health conditions. This page offers information strictly for educational purposes and does not comprehensively cover the current research on psychedelic treatments, including their effectiveness, contraindications, risks, side effects, or other relevant details. For further information, please refer to our Disclaimers in our Terms of Use.